MPM BIOIMPACT LLC
CIK 1687078 · Holdings on Jun 30, 2026 · First reported Aug 14, 2026
Top ten holdings
Q2 2026- CGEM10.81%
- AKTS9.50%
- LQDA6.74%
- RVMD5.62%
- CORT4.09%
- EWTX4.02%
- TVTX3.89%
- DBVT3.67%
- TRVI3.50%
- ALMS3.46%
Share classes counted separately55.30%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- DBVTWeight decreased · -4.74 pp8.41% → 3.67%Shares -1.55M (-29.68%)
- AKTSWeight increased · +2.82 pp6.68% → 9.50%Shares 0 (0.00%)
- LQDAWeight increased · +2.64 pp4.10% → 6.74%Shares -18.98K (-1.35%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CGEMCULLINAN THERAPEUTICS INC230031106 View history and evidence | $177.21M | 10.81% | 9.73M shares | 8.39% → 10.81%+2.42 pp +2.08M (+27.24%) | Added | ↗▾ |
| 02 | AKTSAKTIS ONCOLOGY INC01021M104 View history and evidence | $155.86M | 9.50% | 4.84M shares | 6.68% → 9.50%+2.82 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | LQDALIQUIDIA CORP53635D202 View history and evidence | $110.52M | 6.74% | 1.39M shares | 4.10% → 6.74%+2.64 pp -18.98K (-1.35%) | Reduced | ↗▾ |
| 04 | RVMDREVOLUTION MEDICINES INC76155X100 View history and evidence | $92.23M | 5.62% | 492.48K shares | 3.81% → 5.62%+1.81 pp -14.29K (-2.82%) | Reduced | ↗▾ |
| 05 | CORTCORCEPT THERAPEUTICS INC218352102 View history and evidence | $67.04M | 4.09% | 771.03K shares | 3.07% → 4.09%+1.02 pp -214.67K (-21.78%) | Reduced | ↗▾ |
| 06 | EWTXEDGEWISE THERAPEUTICS INC28036F105 View history and evidence | $65.85M | 4.02% | 1.62M shares | 4.04% → 4.02%-0.02 pp -39.92K (-2.40%) | Reduced | ↗▾ |
| 07 | TVTXTRAVERE THERAPEUTICS INC89422G107 View history and evidence | $63.78M | 3.89% | 1.12M shares | 2.60% → 3.89%+1.29 pp -10.63K (-0.94%) | Reduced | ↗▾ |
| 08 | DBVTDBV TECHNOLOGIES SA-SPON ADR23306J309 View history and evidence | $60.13M | 3.67% | 3.67M shares | 8.41% → 3.67%-4.74 pp -1.55M (-29.68%) | Reduced | ↗▾ |
| 09 | TRVITREVI THERAPEUTICS INC89532M101 View history and evidence | $57.32M | 3.50% | 3.07M shares | 3.04% → 3.50%+0.46 pp -224.85K (-6.82%) | Reduced | ↗▾ |
| 10 | ALMSALUMIS INC022307102 View history and evidence | $56.82M | 3.46% | 2.02M shares | 4.06% → 3.46%-0.60 pp -367.51K (-15.40%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 11
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS INC | Non-derivative | -1,306,261 | -$44.19M | SEC filing ↗ | SEC filing ↗ |
| XENE XENON PHARMACEUTICALS INC | Non-derivative | -588,706 | -$34.23M | SEC filing ↗ | SEC filing ↗ |
| EVMN EVOMMUNE INC | Non-derivative | -1,455,863 | -$33.47M | SEC filing ↗ | SEC filing ↗ |
3 / 11 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1687078 · Period 2026-06-30
Data loaded 2026-09-23 · First reported 2026-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1639957110
}Research all 37 reported holdings.
This page includes 30 of 37 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 37 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1687078","quarter":"2026Q2","page_size":100}
get_institutional_manager_history
{"cik":"1687078","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.